Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Orthopediatrics (KIDS) EBIT Margin (2016 - 2025)

Orthopediatrics has reported EBIT Margin over the past 10 years, most recently at 13.27% for Q4 2025.

  • Quarterly results put EBIT Margin at 13.27% for Q4 2025, up 1342.0% from a year ago — trailing twelve months through Dec 2025 was 16.6% (up 50.0% YoY), and the annual figure for FY2025 was 16.6%, up 50.0%.
  • EBIT Margin for Q4 2025 was 13.27% at Orthopediatrics, up from 15.39% in the prior quarter.
  • Over the last five years, EBIT Margin for KIDS hit a ceiling of 10.2% in Q3 2024 and a floor of 27.83% in Q1 2021.
  • Median EBIT Margin over the past 5 years was 18.68% (2022), compared with a mean of 18.56%.
  • Biggest five-year swings in EBIT Margin: soared 4493bps in 2021 and later crashed -672bps in 2025.
  • Orthopediatrics' EBIT Margin stood at 22.41% in 2021, then dropped by -20bps to 26.81% in 2022, then grew by 20bps to 21.44% in 2023, then decreased by -24bps to 26.69% in 2024, then skyrocketed by 50bps to 13.27% in 2025.
  • The last three reported values for EBIT Margin were 13.27% (Q4 2025), 15.39% (Q3 2025), and 17.45% (Q2 2025) per Business Quant data.